Literature DB >> 16432238

The methyl-CpG binding protein MBD1 is required for PML-RARalpha function.

Raffaella Villa1, Lluis Morey, Veronica A Raker, Marcus Buschbeck, Arantxa Gutierrez, Francesca De Santis, Massimo Corsaro, Florencio Varas, Daniela Bossi, Saverio Minucci, Pier Giuseppe Pelicci, Luciano Di Croce.   

Abstract

PML-RARalpha induces a block of hematopoietic differentiation and acute promyelocytic leukemia. This block is based on its capacity to inactivate target genes by recruiting histone deacetylase (HDAC) and DNA methyltransferase activities. Here we report that MBD1, a member of a conserved family of proteins able to bind methylated DNA, cooperates with PML-RARalpha in transcriptional repression and cellular transformation. PML-RARalpha recruits MBD1 to its target promoter through an HDAC3-mediated mechanism. Binding of HDAC3 and MBD1 is not confined to the promoter region but instead is spread over the locus. Knock-down of HDAC3 expression by RNA interference in acute promyelocytic leukemia cells alleviates PML-RAR-induced promoter silencing. We further demonstrate that retroviral expression of dominant-negative mutants of MBD1 in hematopoietic precursors compromises the ability of PML-RARalpha to block their differentiation and thus restored cell differentiation. Our results demonstrate that PML-RARalpha functions by recruiting an HDAC3-MBD1 complex that contributes to the establishment and maintenance of the silenced chromatin state.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432238      PMCID: PMC1360559          DOI: 10.1073/pnas.0509343103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  DNA methylation in health and disease.

Authors:  K D Robertson; A P Wolffe
Journal:  Nat Rev Genet       Date:  2000-10       Impact factor: 53.242

Review 2.  Histone deacetylases: silencers for hire.

Authors:  H H Ng; A Bird
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

3.  Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.

Authors:  S Minucci; M Maccarana; M Cioce; P De Luca; V Gelmetti; S Segalla; L Di Croce; S Giavara; C Matteucci; A Gobbi; A Bianchini; E Colombo; I Schiavoni; G Badaracco; X Hu; M A Lazar; N Landsberger; C Nervi; P G Pelicci
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

Review 4.  Controlling nuclear receptors: the circular logic of cofactor cycles.

Authors:  Valentina Perissi; Michael G Rosenfeld
Journal:  Nat Rev Mol Cell Biol       Date:  2005-07       Impact factor: 94.444

5.  Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.

Authors:  R Z Chen; S Akbarian; M Tudor; R Jaenisch
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

6.  Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA.

Authors:  I Ohki; N Shimotake; N Fujita; J Jee; T Ikegami; M Nakao; M Shirakawa
Journal:  Cell       Date:  2001-05-18       Impact factor: 41.582

7.  Rb targets histone H3 methylation and HP1 to promoters.

Authors:  S J Nielsen; R Schneider; U M Bauer; A J Bannister; A Morrison; D O'Carroll; R Firestein; M Cleary; T Jenuwein; R E Herrera; T Kouzarides
Journal:  Nature       Date:  2001-08-02       Impact factor: 49.962

8.  Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3.

Authors:  J Li; J Wang; J Wang; Z Nawaz; J M Liu; J Qin; J Wong
Journal:  EMBO J       Date:  2000-08-15       Impact factor: 11.598

9.  Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1.

Authors:  N Fujita; N Shimotake; I Ohki; T Chiba; H Saya; M Shirakawa; M Nakao
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

10.  The histone deacetylase-3 complex contains nuclear receptor corepressors.

Authors:  Y D Wen; V Perissi; L M Staszewski; W M Yang; A Krones; C K Glass; M G Rosenfeld; E Seto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

View more
  35 in total

1.  PML-RAR{alpha} and Dnmt3a1 cooperate in vivo to promote acute promyelocytic leukemia.

Authors:  Deepa Subramanyam; Cassandra D Belair; Keegan Q Barry-Holson; Haijiang Lin; Scott C Kogan; Emmanuelle Passegué; Robert Blelloch
Journal:  Cancer Res       Date:  2010-09-21       Impact factor: 12.701

2.  Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.

Authors:  Peili Gu; Damien Le Menuet; Arthur C-K Chung; Austin J Cooney
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

3.  Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip.

Authors:  Claudia Hoemme; Abdul Peerzada; Gerhard Behre; Yipeng Wang; Michael McClelland; Kay Nieselt; Matthias Zschunke; Christine Disselhoff; Shuchi Agrawal; Fabienne Isken; Nicola Tidow; Wolfgang E Berdel; Hubert Serve; Carsten Müller-Tidow
Journal:  Blood       Date:  2007-11-16       Impact factor: 22.113

Review 4.  Epigenetics in acute myeloid leukemia.

Authors:  Christoph Plass; Christopher Oakes; William Blum; Guido Marcucci
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

Review 5.  Dietary manipulation of histone structure and function.

Authors:  Barbara Delage; Roderick H Dashwood
Journal:  Annu Rev Nutr       Date:  2008       Impact factor: 11.848

6.  The histone variant macroH2A is an epigenetic regulator of key developmental genes.

Authors:  Marcus Buschbeck; Iris Uribesalgo; Indra Wibowo; Pau Rué; David Martin; Arantxa Gutierrez; Lluís Morey; Roderic Guigó; Hernán López-Schier; Luciano Di Croce
Journal:  Nat Struct Mol Biol       Date:  2009-09-06       Impact factor: 15.369

Review 7.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

8.  The Roles of the Methyl-CpG Binding Proteins in Cancer.

Authors:  Lee Parry; Alan R Clarke
Journal:  Genes Cancer       Date:  2011-06

Review 9.  Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia.

Authors:  Akihiro Tomita; Hitoshi Kiyoi; Tomoki Naoe
Journal:  Int J Hematol       Date:  2013-05-14       Impact factor: 2.490

Review 10.  DNA methylation and methyl-CpG binding proteins: developmental requirements and function.

Authors:  Ozren Bogdanović; Gert Jan C Veenstra
Journal:  Chromosoma       Date:  2009-06-09       Impact factor: 4.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.